porno izle
porno
erotik film
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Product & Service Announcements

Absolute Antibody Adds SeqPack™ Hybridoma Preservation Kit to Antibody Sequencing Service

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, announced the availability of the SeqPack™ Hybridoma Preservation Kit, which streamlines the sample submission process for hybridoma sequencing customers worldwide. The kit saves customers both time and money by eliminating the need to ship hybridoma cells on dry ice.

Read the rest of entry »

Enesi Pharma to Develop Thermostable, Solid Dose DNA Vaccine Targeting Zika Virus under New Partnership with The University of Adelaide

OXFORD, UK – 03 September 2020 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection of pregnant women and the resultant congenital effects in the unborn child.

Read the rest of entry »

Yourgene Health: Today announces the launch of IONA® Nx NIPT workflow

Manchester, UK : Yourgene (AIM: YGEN), the international molecular diagnostics group, announced today  the launch of IONA® Nx NIPT workflow, the Company’s new innovative non-invasive prenatal test (‘NIPT’). The IONA Nx seeks to offer clinical labs a high performing, flexible, scalable and innovative NIPT service inhouse and is developed to run on the Illumina Nextseq 550 Dx platform for next generation sequencing.

Read the rest of entry »

Taylor Wessing Webinar: 'Optimising exits for European technology companies'

In collaboration with Silverpeak, this session will provide practical guidelines and best practice for those seeking to sell or make a partial realisation in the current environment. You will hear real life stories from an entrepreneur's recent exit experience together with a viewpoint from the private equity industry. 

TaylorWessing, new OBN sponsors are offering this webinar on Thursday 17 September 2020, 0830 - 1000.  Click here to REGISTER.

Antiviral nanomaterials join the fight against SARS-Cov-2

AMSBIO: New Cytometry Service Provides Automated Analysis of Fluorescent Biomarkers

AMSBIO announce a new service designed to provide high-content cytometry data on cells and tissues enabling the automated analysis of fluorescent biomarkers on living cells or long-term stored biobanked cells and tissues.  Leveraging the innovative ChipCytometry platform, AMSBIO is able to offer a complete workflow solution (products and services) for high-content cytometry on cells and tissues, from sample preparation and biobanking to biomarker analysis and data mining. The ChipCytometry platform operates by immobilizing cells in microfluidic chips, which are later stained with antibodies for multiplex biomarker detection. Using the ChipCytometry platform - AMSBIO can offer quantitative analysis of a virtually unlimited number of protein biomarkers in a single sample. AMSBIO is also to offer custom assays facilitating analysis of almost any antibody / biomarker target. Not only can this technology deliver quantitative biomarker analysis but it ca ...

Read the rest of entry »

Absolute Antibody Offers SARS-CoV-2 Neutralizing Antibodies Derived from COVID-19 Patients

Redcar, UK:  Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19. The antibodies, originally generated by Fred Hutchinson Cancer Research Center, have been engineered into recombinant formats useful for COVID-19 research and diagnostic development. They are now available to scientists and diagnostic developers worldwide via Absolute Antibody’s online catalog. The new antibodies were generated from the blood cells of an infected COVID-19 patient and have shown in a recent article to display neutralizing activity against SARS-CoV-2, the coronavirus that causes COVID-19. Two antibody clones (CV1 and CV30) each bound the SARS-CoV-2 spike glycoprotein, with CV30 also shown to bind the receptor binding domain (RBD) and inhibit the interaction with the host cell receptor ACE2. Both antibodies are now available in a variety of spe ...

Read the rest of entry »

AMSBIO: Differentiation of Human iPS and ES Cells

Oxford, UK: AMSBIO has introduced StemFit® for Differentiation - a new chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells. The unique chemically defined composition of StemFit® for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation. Free of animal- and human-derived components, StemFit® for Differentiation can be used to eliminate the risk of immunogenic contamination. Applications proven to benefit from StemFit® for Differentiation include: lineage-specific (endodermal, mesodermal and ectodermal) differentiation where this new product is used to replace serum-free supplements, as well as spontaneous differentiation of hiPSCs to organoids via embryoid body formation. Used in combination with StemFit Basic feeder-free medium with iMatrix-511 laminin as extracellular matrix, StemFit® for Differentiation enables res ...

Read the rest of entry »

AMSBIO: Tailored Solutions for Exosome-related Research

Oxford, UK:  AMSBIO offers a comprehensive range of end-to-end services for exosome purification, characterization, and engineering. Exosomes are small endosome derived lipid nanoparticles, actively secreted by exocytosis in most living cells. Acting on tissues in both the local environment and further afield, they function as important signal carriers through their transport of RNA, proteins, lipids and DNA. Exosomes are involved in a wide range of normal and pathogenic processes, making exosome research crucial in multiple areas. Exosomes are a type of extracellular vesicle (EV) that show promise for use as unique drug carriers to deliver protease inhibitors to treat COVID-19. In this application, EVs may provide targeted delivery of protease inhibitors, with fewer systemic side effects. More importantly, EVs are highly suitable for major aseptic processing and can be upscaled for mass production. Currently, the FDA is backing applications to treat COVID-19, which provides a very good ...

Read the rest of entry »

New England Biolabs’ SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes

The research use only kit can be used as a simple alternative to RT-qPCR for SARS-CoV-2 analysis.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.